Recruiting

Memory Enhancement

Sponsor:

Kessler Foundation

Code:

NCT07127367

Conditions

Stoke

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

Memory Training

Study Details

Brief summary:

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons following stroke

Conditions

Stoke

Study ID

NCT07127367

Start date

Jan 5, 2026

Status verified date

Jun, 2026

Completion date

Oct, 2026

Anticipated

Primary completion date

Oct, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Stroke over 1 year ago
  • Memory challenges

Exclusion Criteria:

  • Aphasia
  • non English speaking

Study Design

Enrollment

30 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: KFmSMT

Memory training on computer, 2 times per week for 5 weeks

sham comparator: Memory program

Memory training on computer, 2 times per week for 5 weeks

Interventions

Memory Training

Memory retraining exercises will be administered on a laptop computer twice a week for five weeks (10 training sessions).

Primary outcome measure

  • CVLT-III [ Time Frame: baseline, week 7 and 6 months following intervention. ]
  • modified Ecological Memory Simulations (EMS) [ Time Frame: Baseline, week 7, and 6 months following intervention ]

Central Contacts and Locations

Central contacts

Nancy Moore, M.A.

19733248450nbmoore@kesslerfoundation.org

Locations

Kessler Foundation

Recruiting

East Hanover, New Jersey, United States, 07936

Contacts

Nancy Moore, MA

973.324.8450nbmoore@kesslerfoundation.org

More Information

Sponsor

Kessler Foundation

Last update posted

Sep 8, 2026

Last verified

Jun, 2026

Keywords

  • Memory
  • Learning
  • Stroke

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Kessler Foundation on 2026-09-08.